The drug, Mazdutide, is the world's first and currently only GCG/GLP-1 dual receptor agonist targeting both weight loss and ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...

Innovation in clinical diagnostics is accelerating, with breakthroughs that promise to make testing more precise, less invasive and more accessible. These advancements are expected not only to benefit ...

Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Detection of cancer before a clinical diagnosis could give patients and caregivers more time for intervention and may lead to ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...

Hair growth serums incorporate active ingredients that encourage hair thickening. One of the most effective ingredients is ...

This Small-cap Pharma Stock, engaged in the research and development of innovative pharmaceutical products, focusing on therapies for unmet medical needs, hit a 20 percent lower circuit after the ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.